Volume 1 · Issue 5
Neurodegeneration & the Aging Brain
From cognitive reserve to longitudinal biomarkers, this issue examines the progression of neurodegenerative conditions and the evidence used to distinguish aging from disease.
100 Creative Commons readings · Paulina Valenzuela, MD, Editor-in-Chief
Issue 5 · Reading list
Explore the research
100 readings · Page 1 of 5
- Original article
Alzheimer’s disease and related dementias · CC BY 4.0
The Amyloid-β Pathway in Alzheimer's Disease.
Harald Hampel, John Hardy, Kaj Blennow, Christopher Chen et al.
Molecular psychiatry · 2021
- Original article
Alzheimer’s disease and related dementias · CC BY 4.0
New insights into the genetic etiology of Alzheimer's disease and related dementias.
Céline Bellenguez, Fahri Küçükali, Iris E Jansen, Luca Kleineidam et al.
Nature genetics · 2022
- Original article
Alzheimer’s disease and related dementias · CC BY 4.0
The amyloid hypothesis of Alzheimer's disease at 25 years.
Dennis J Selkoe, John Hardy
EMBO molecular medicine · 2016
- Original article
Alzheimer’s disease and related dementias · CC BY 4.0
The neuropathological diagnosis of Alzheimer's disease.
Michael A DeTure, Dennis W Dickson
Molecular neurodegeneration · 2019
- Original article
Alzheimer’s disease and related dementias · CC BY 4.0
Global, regional, and national burden of Alzheimer's disease and other dementias, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.
GBD 2016 Dementia Collaborators
The Lancet. Neurology · 2018
- Original article
Alzheimer’s disease and related dementias · CC BY 4.0
Comprehensive Review on Alzheimer's Disease: Causes and Treatment.
Zeinab Breijyeh, Rafik Karaman
Molecules (Basel, Switzerland) · 2020
- Original article
Alzheimer’s disease and related dementias · CC BY 4.0
Gut microbiome alterations in Alzheimer's disease.
Nicholas M Vogt, Robert L Kerby, Kimberly A Dill-McFarland, Sandra J Harding et al.
Scientific reports · 2017
- Original article
Alzheimer’s disease and related dementias · CC BY 4.0
Porphyromonas gingivalis in Alzheimer's disease brains: Evidence for disease causation and treatment with small-molecule inhibitors.
Stephen S Dominy, Casey Lynch, Florian Ermini, Malgorzata Benedyk et al.
Science advances · 2019
- Original article
Alzheimer’s disease and related dementias · CC0 1.0
Alzheimer's disease drug-development pipeline: few candidates, frequent failures.
Jeffrey L Cummings, Travis Morstorf, Kate Zhong
Alzheimer's research & therapy · 2014
- Original article
Alzheimer’s disease and related dementias · CC BY 4.0
Recent advances in Alzheimer's disease: Mechanisms, clinical trials and new drug development strategies.
Jifa Zhang, Yinglu Zhang, Jiaxing Wang, Yilin Xia et al.
Signal transduction and targeted therapy · 2024
- Original article
Alzheimer’s disease and related dementias · CC BY 4.0
Mitochondria dysfunction in the pathogenesis of Alzheimer's disease: recent advances.
Wenzhang Wang, Fanpeng Zhao, Xiaopin Ma, George Perry et al.
Molecular neurodegeneration · 2020
- Original article
Alzheimer’s disease and related dementias · CC BY 4.0
Diagnostic Accuracy of a Plasma Phosphorylated Tau 217 Immunoassay for Alzheimer Disease Pathology.
Nicholas J Ashton, Wagner S Brum, Guglielmo Di Molfetta, Andrea L Benedet et al.
JAMA neurology · 2024
- Original article
Alzheimer’s disease and related dementias · CC BY 4.0
Early role of vascular dysregulation on late-onset Alzheimer's disease based on multifactorial data-driven analysis.
Y Iturria-Medina, R C Sotero, P J Toussaint, J M Mateos-Pérez et al.
Nature communications · 2016
- Original article
Alzheimer’s disease and related dementias · CC BY 4.0
Amyloid β-based therapy for Alzheimer's disease: challenges, successes and future.
Yun Zhang, Huaqiu Chen, Ran Li, Keenan Sterling et al.
Signal transduction and targeted therapy · 2023
- Original article
Alzheimer’s disease and related dementias · CC BY 4.0
Sodium oligomannate therapeutically remodels gut microbiota and suppresses gut bacterial amino acids-shaped neuroinflammation to inhibit Alzheimer's disease progression.
Xinyi Wang, Guangqiang Sun, Teng Feng, Jing Zhang et al.
Cell research · 2019
- Original article
Alzheimer’s disease and related dementias · CC BY 4.0
A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer's disease with lecanemab, an anti-Aβ protofibril antibody.
Chad J Swanson, Yong Zhang, Shobha Dhadda, Jinping Wang et al.
Alzheimer's research & therapy · 2021
- Original article
Alzheimer’s disease and related dementias · CC BY 4.0
Sustained microglial depletion with CSF1R inhibitor impairs parenchymal plaque development in an Alzheimer's disease model.
Elizabeth Spangenberg, Paul L Severson, Lindsay A Hohsfield, Joshua Crapser et al.
Nature communications · 2019
- Original article
Alzheimer’s disease and related dementias · CC BY 4.0
Loss of ferroportin induces memory impairment by promoting ferroptosis in Alzheimer's disease.
Wen-Dai Bao, Pei Pang, Xiao-Ting Zhou, Fan Hu et al.
Cell death and differentiation · 2021
- Original article
Alzheimer’s disease and related dementias · CC BY 4.0
Blood-brain barrier opening in Alzheimer's disease using MR-guided focused ultrasound.
Nir Lipsman, Ying Meng, Allison J Bethune, Yuexi Huang et al.
Nature communications · 2018
- Original article
Alzheimer’s disease and related dementias · CC BY 4.0
Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer's disease.
Tiantian Guo, Denghong Zhang, Yuzhe Zeng, Timothy Y Huang et al.
Molecular neurodegeneration · 2020
